Human Xt-M (HUMX.M) AI Stock Analysis

• Market Cap: 7.38M
• Dividend Yield: N/A
• Average Volume (3M): 8.06K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.14
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IL
• Employees: 21
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 26,756,048
• 10 Day Avg. Volume: 74
• 30 Day Avg. Volume: 8,059
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: ―

Human Xt's stock performance is weighed down by significant financial difficulties, including declining revenues and persistent losses. The technical analysis is mixed, showing some potential for volatility but no clear trend. Valuation metrics are unattractive due to negative earnings. The company's dire financial health is the primary concern, overshadowing any technical or valuation considerations.

Human Xt-M Business Overview & Revenue Model

Company Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.

How the Company Makes Money

Human Xt (HUMX) generates revenue through the sale of its smart wearable devices and augmented reality applications, which are available to both individual consumers and corporate clients. The company also offers AI-driven software solutions on a subscription basis, providing continuous updates and support. Key revenue streams include direct product sales, subscription fees for software services, and partnerships with technology firms to integrate HUMX's solutions into broader ecosystems. Additionally, strategic alliances with enterprise clients in various industries allow the company to create customized solutions that cater to specific business needs, thereby enhancing its earnings.

Human Xt-M Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Human Xt-M Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 27.60
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HUMX.M, the sentiment is Negative. The current price of 27.6 is below the 20-day moving average (MA) of 27.66, above the 50-day MA of 27.26, and below the 200-day MA of 30.90, indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 53.38 is Neutral, neither overbought nor oversold. The STOCH value of 100.36 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HUMX.M.

Human Xt-M Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NICE	77 Outperform	30.13B	16.02	14.40%	―	8.81%	32.96%
PERI	57 Neutral	$435.06M	-81.73	-0.69%	―	-38.18%	-107.00%
HUMX.M	40 Underperform	7.38M	―	―	―	―	―
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%